Airo Group Holdings, Inc. AIRO 深 滬
已收盤 02-06 16:00:00 美东时间
9.64
+1.160
+13.68%
華盛通- 最 高9.70
- 今 開8.75
- 成交量 43.99万股
- 最 低 8.63
- 昨 收 8.48
- 總市值 3.02亿
- 52周最高 39.07
- 市盈率 靜 --
- 換手率 1.41%
- 52周最低 7.28
- 委 比 -79.05%
- 總股本 3130.38万
- 歷史最高 39.07
- 量 比 0.89
- 振 幅 12.62%
- 歷史最低 7.28
- 每 手 1
- 風險率 6.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
Mizuho Maintains Outperform on AIRO Group Holdings, Lowers Price Target to $20
Mizuho analyst Brett Linzey maintains AIRO Group Holdings (NASDAQ:AIRO) with a Outperform and lowers the price target from $25 to $20.
01-05 21:52
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
2025-11-25 10:27
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
2025-11-24 11:23
Cantor Fitzgerald Maintains Overweight on AIRO Group Holdings, Lowers Price Target to $20
Cantor Fitzgerald analyst Colin Canfield maintains AIRO Group Holdings (NASDAQ:AIRO) with a Overweight and lowers the price target from $35 to $20.
2025-11-21 22:27
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
AIRO Looks To Accelerate Combat Drone Output With New European Partner
AIRO announced a joint venture with Nord-Drone to deliver combat-proven drone technology to U.S. and NATO allies.
2025-11-14 20:41
AIRO Group Holdings Q3 2025 GAAP EPS $(0.28) Up From $(1.85) YoY, Sales $6.284M Down From $23.685M YoY
AIRO Group Holdings (NASDAQ:AIRO) reported quarterly losses of $(0.28) per share. This is a 84.86 percent increase over losses of $(1.85) per share from the same period last year. The company reported $6.284 million in
2025-11-14 19:41
Earnings Scheduled For November 14, 2025
Companies Reporting Before The Bell • Inhibrx Biosciences (NASDAQ:INBX) is expe...
2025-11-14 19:11
AIRO Group Announces Role In MAturity of Collaborative Avoidance Development Approach Initiative
AIRO Group Holdings (NASDAQ:AIRO) (AIRO) is pleased to announce its active role in the MACADA (MAturity of Collaborative Avoidance Development Approach) initiative, a strategic research and development effort focused on
2025-11-11 20:08
